Topical nasal steroids Topical nasal steroids are anti-inflammatory nutrient drugs that stop the allergic reaction. In addition to other beneficial solution and nutrient actions, they reduce the number of mast cells in the nose and reduce mucus secretion and nasal swelling. The combination of antihistamines and nasal steroids is a very effective way to treat allergic rhinitis. This medication solution should not be confused with anabolic steroids that have serious side effects. Cromolyn sodium Cromolyn sodium stops allergic reactions from starting. It is administered as a nasal spray, and it can prevent the release of chemicals like histamine from the mast cell. Click here for allergy medication online.

Studies indicate that ingested oral cyanocobalamin tablets are ineffective in the treatment of allergic disease, perhaps because once ingested, they are directly metabolized in the nutrient and solution liver. When B12 is delivered via injection or lozenge it passes throughout the bloodstream before arriving at nutrient the liver. It is during this first pass in its native form that it is believed to exert its therapeutic effect. CLINICAL RESEARCH: "The World Health Organization (WHO) recognizes allergic rhinitis (hay fever), sinusitis, asthma,...conjunctivitis, urticaria, eczema, dermatitis (contact and atopic)...allergic and migraine headache...as diseases in which IgE-mediated allergy may be involved."1 In 1988, asthma and allergic rhinitis subjects were treated with B12. Total IgE, solution specific IgE and pulmonary lung functions were taken at days 45, 150 and 180 from baseline. Eight of the 9 subjects had reduced IgE. 2 In 1989 open label studies at two sites in Riverside County, CA in 1989. Sixteen of the 17 subjects had lowered IgE levels from Day 0 to Day 30.3

In 1990 study in San Diego, CA the 5 active subjects with allergic rhinitis had a lowered total serum IgE from Day 0 to Day 90 while 4 placebo subjects, (2 with allergic rhinitis, 1 with asthma and 1 with both), had flat or increased IgE levels.4 In a randomized, double-blind, placebo controlled study of symptoms and serum IgE levels in San Diego, CA in mid-1991, subjects had allergic rhinitis and/or asthma. Serum was drawn at Day 0 and Day 30. nutrient Seven of the 10 active solution treated subjects had a reduction in total serum IgE levels. In nutrient 10 placebo treated subjects, solution 5 had levels of total serum IgE that stayed the nutrient same (plus or minus 5%), 3 decreased and 2 increased.5 Statistical analysis of the open-label study as well as the solution double-blind randomized placebo controlled study have shown a significant effect of vitamin B12 in lowering serum IgE concentrations.